Latent autoimmune diabetes - a diabetes mellitus 1,5 type?


Cite item

Full Text

Abstract

Currently, one of the variants of the current autoimmune diabetes mellitus is widely studied - it is a slowly progressing autoimmune diabetes of adults (latent autoimmune diabetes of adults, LADA). It is accompanied by an atypical clinical picture for both classical type 1 diabetes mellitus and type 2. Despite the presence of positive autoantibodies, LADA is characterized by a slow rate of autoimmune destruction, and therefore the need for insulin therapy does not appear immediately. In the proposed article, we tried to figure out which type of sugar diabetes by its course LADA is closer. Also, the role of self-monitoring of glycemia in patients with LADA is highlighted

About the authors

N. E Khachaturyan

A.S.Loginov Moscow Clinical Scientific Practical Center of the Department of Health of Moscow; A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation

Email: nane18@list.ru
врач-эндокринолог; ст. лаборант каф. эндокринологии и диабетологии 111123, Russian Federation, Moscow, sh. Entuziastov, d. 86; 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1

References

  1. Глобальный доклад по диабету ВОЗ, 2016.
  2. Landin-Olsson M. Latent autoimmune diabetes in adults. Ann NY Acad Sci 2002; 958: 112-6.
  3. Leslie R.D, Williams R, Pozzilli P. Clinical review: Type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow. J Clin Endocrinol Metab 2006; 91 (5): 1654-9.
  4. Tuomi T, Groop L, Zimmet P.Z, Merrill J et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 1993; 42: 359-62.
  5. Tuomi T, Zimmet P, Mackay I.R et al. Latent Autoimmune Diabetes Mellitus in Adults (LADA): the Role of Antibodies to Glutamic Acid Decarboxylase in Diagnosis and Prediction of Insulin Dependency. Diabetes 1994; 11: 299-303.
  6. Zimmet P.Z. The pathogenesis and prevention of diabetes in adults: genes, autoimmunity, and demography. Diabetes Care 1995; 18: 1050-64.
  7. Fourlanos S, Perry C, Stein M.S et al. A clinical screening tool identifies autoimmune diabetes in adults. Diabetes Care 2006; 29 (5): 970-5.
  8. Behme M.T, Dupre J, Harris S.B et al. Insulin resistance in latent autoimmune diabetes of adulthood. Ann NY Acad Sci 2003; 1005: 374-7.
  9. Carlsson S, Midthjell K, Tesfamarian M.Y et al. Age, overweight and physical inactivity increase the risk of latent autoimmune diabetes in adults: results from the Nord-Trоndelag health study. Diabetologia 2007; 50 (1): 55-8.
  10. Nambam B, Aggarwal S, Jain A. Latent autoimmune diabetes in adults: A distinct but heterogeneous clinical entity. World J Diabetes 2010; 1 (4): 111-5.
  11. Thunander M, Thorgeirsson H, Törn C et al. b-cell function and metabolic control in latent autoimmune diabetes in adults with early insulin versus conventional treatment: a 3-year follow-up. Eur J Endocrinol 2011; 164 (2): 239-45.
  12. Maruyama T, Shimada A, Kanatsuka A et al. Multicenter prevention trial of slowly progressive type 1 diabetes with small dose of insulin (the Tokyo study): preliminary report. Ann N Y Acad Sci 2003; 1005: 362-9.
  13. Takino H, Yamasaki H, Sera Y et al. The preliminary report from the nation-wide prevention study for type 1 diabetes initially diagnosed as type 2 in Japan. Diabetes Metab Rev 1998; 14: 334-5.
  14. Kobayashi T, Nakanishi K, Murase T, Kosaka K. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes 1996; 45: 622-6.
  15. Алгоритмы специализированной медицинской помощи больных сахарным диабетом. Под ред. И.И.Дедова, М.В.Шестаковой. Вып. 8. М., 2017.
  16. Caswell M et al. Accuracy and User Performance Evaluation of a Blood Glucose Monitoring System. Diabetes Technol Ther 2015; 3: 1-7.

Copyright (c) 2018 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies